Hydrochloric Acid

Hydrochloric Acid

SCHEMBL15967490

CC(C)[Si](O[Si](C(C)C)(C(C)C)C(C)C)(C(C)C)C(C)C.Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1695676 0.77
SCHEMBL15429244 0.77
2-Bromoethanol SCHEMBL4943481 0.73 TSHR (0.30)
SCHEMBL2502585 0.72
SCHEMBL15161898 0.72
Hydrochloric Acid SCHEMBL31112620 0.72
SCHEMBL15915168 0.70
SCHEMBL15429243 0.70
SCHEMBL15429242 0.70
SCHEMBL15915876 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260015378-A1 DISULFIDE-LINKED REVERSIBLE TERMINATORS CENTRILLION TECHNOLOGY HOLDINGS CORPORATION (KY) 2026-01-15 US disclosed
US-12258368-B2 Disulfide-linked reversible terminators CENTRILLION TECHNOLOGY HOLDINGS CORPORATION (KY) 2025-03-25 US disclosed
US-20220389049-A1 REVERSIBLE TERMINATORS FOR DNA SEQUENCING AND METHODS OF USING THE SAME CENTRILLION TECHNOLOGY HOLDINGS CORPORATION (VG) 2022-12-08 US disclosed
US-20220048940-A1 DISULFIDE-LINKED REVERSIBLE TERMINATORS CENTRILLION TECHNOLOGY HOLDINGS CORPORATION (KY) 2022-02-17 US disclosed
US-11180522-B2 Disulfide-linked reversible terminators CENTRILLION TECHNOLOGY HOLDINGS CORPORATION (KY) 2021-11-23 US disclosed
EP-3856753-A1 DISULFIDE-LINKED REVERSIBLE TERMINATORS Centrillion Technology Holdings Corporation (KY) 2021-08-04 EP disclosed
WO-2021067970-A1 REVERSIBLE TERMINATORS FOR DNA SEQUENCING AND METHODS OF USING THE SAME CENTRILLION TECHNOLOGIES, INC. (US) 2021-04-08 WO disclosed
WO-2020069424-A1 DISULFIDE-LINKED REVERSIBLE TERMINATORS CENTRILLION TECHNOLOGIES, INC. (US) 2020-04-02 WO disclosed
EP-3091026-B1 DISULFIDE-LINKED REVERSIBLE TERMINATORS CENTRILLION TECH HOLDINGS CORP (KY) 2019-02-20 EP disclosed
US-10059986-B2 Reversible terminator molecules and methods of their use CENTRILLION TECHNOLOGY HOLDINGS CORPORATION (US) 2018-08-28 US disclosed
US-20170218441-A1 REVERSIBLE TERMINATOR MOLECULES AND METHODS OF THEIR USE CENTRILLION TECHNOLOGY HOLDINGS CORPORATION (US) 2017-08-03 US disclosed
US-9650406-B2 Reversible terminator molecules and methods of their use CENTRILLION TECHNOLOGY HOLDINGS CORPORATION (US) 2017-05-16 US disclosed
US-20160355541-A1 DISULFIDE-LINKED REVERSIBLE TERMINATORS CENTRILLION TECHNOLOGY HOLDINGS CORPORATION (KY) 2016-12-08 US disclosed
WO-2016182984-A1 DISULFIDE-LINKED REVERSIBLE TERMINATORS CENTRILLION TECHNOLOGY HOLDINGS CORPORATION (KY) 2016-11-17 WO disclosed
EP-3091026-A1 DISULFIDE-LINKED REVERSIBLE TERMINATORS Centrillion Technology Holdings Corporation (KY) 2016-11-09 EP disclosed
US-20140242579-A1 REVERSIBLE TERMINATOR MOLECULES AND METHODS OF THEIR USE CENTRILLION TECHNOLOGY HOLDINGS CORPORATION 2014-08-28 US disclosed